Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Gloria Salvo is a leading gynecologic oncologist whose research focuses on fertility-sparing surgery for early-stage cervical cancer, particularly radical trachelectomy. Her landmark contributions include the International Radical Trachelectomy Assessment (IRTA) Study, which systematically compared open versus minimally invasive surgical approaches—a critical question in preserving fertility without compromising oncologic outcomes. The 2021 IRTA publication (61 citations) and its 2019 precursor (53 citations) have shaped global surgical standards, demonstrating her impact on clinical practice. Dr. Salvo has also pioneered the use of simple trachelectomy with pelvic lymphadenectomy in pregnant patients with stage IB1 cervical cancer (≥2 cm), offering a viable pathway to delay treatment until fetal viability (17 citations). Her work on minimally invasive techniques (15 citations) further refines surgical considerations to optimize patient outcomes. With over 130 cumulative citations, Dr. Salvo’s research bridges the gap between aggressive cancer control and reproductive preservation, making her a pivotal figure in gynecologic oncology. Her studies are essential reading for clinicians and researchers dedicated to advancing fertility-sparing options in cervical cancer care.